Peer-reviewedCC BYAdvanced Science
Biomimetic Nanoplatform for Fibrosis Remodeling and Anti‐PD‐1 Potentiation via Cu+/Ca2+ Ion Dysregulation and TGF‐β Inhibition in PDAC
- 1Sichuan University
Related
- Low‐Density Lipoprotein Receptor‐Targeted Biomimetic Nanoplatform Suppresses Glioblastoma Stemness and Remodels Antitumor Immunity via Dual Metabolic Disruption
- A lipoprotein-biomimetic nanoplatform for oncogenic KRAS mutation-specific lysosome-targeting protein degradation.
- Biomimetic sequential targeted nanoplatform for synergistic thrombolysis in ischemic stroke.
- Ultrasound‐Activated Ce(IV)‐Integrated Biomimetic Nanoplatform for Oxygenation‐Reinforced Gas‐Sonodynamic Ferroptosis and cGAS–STING‐Driven Antitumor Immunity
- A biomimetic gas-protein co-delivery nanoplatform targets mitochondrial stress and GSDME activation for glioblastoma immunotherapy.
BibTeX
@article{li2026biomimetic,
title = {{Biomimetic Nanoplatform for Fibrosis Remodeling and Anti‐PD‐1 Potentiation via Cu+/Ca2+ Ion Dysregulation and TGF‐β Inhibition in PDAC}},
author = {Jianmei Li and Qinlong Wen and Jie Dai and Li Yang and Feng Xiong and Zhigong Wei and Xingchen Peng},
journal = {Advanced Science},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13690972},
note = {CC BY},
}
RIS
TY - JOUR
TI - Biomimetic Nanoplatform for Fibrosis Remodeling and Anti‐PD‐1 Potentiation via Cu+/Ca2+ Ion Dysregulation and TGF‐β Inhibition in PDAC
AU - Jianmei Li
AU - Qinlong Wen
AU - Jie Dai
AU - Li Yang
AU - Feng Xiong
AU - Zhigong Wei
AU - Xingchen Peng
PY - 2026
DA - 2026/10/22
JO - Advanced Science
UR - https://europepmc.org/article/PMC/PMC13690972
SN - 2198-3844
ER -